Start: 09 Nov 2021, 14:15
End: 09 Nov 2021, 15:15
Chair: Mr Dale Vimalachandran, University of Liverpool, UK
This session is supported by an unrestricted grant from NIHR. They have no involvement in topic or speaker selection.
Abstract title: FOCUS4: lessons learnt from ten years of the first molecularly stratified adaptive trial platform in metastatic colorectal cancer
Abstract title: FOCUS4-N: trial results and individual patient data meta-analysis of maintenance therapy versus active monitoring for patients with first line metastatic colorectal cancer
Abstract title: FOCUS4-C: WEE1 inhibition in patients with TP53 and RAS dual mutant first line metastatic colorectal cancer: A randomized phase II trial comparing adavosertib (AZD1775) with active monitoring